Putnam BioRevolution ETF
NYSE Arca:SYNB

  • LAST PRICE
    29.70
  • TODAY'S CHANGE (%)
    -0.83 (-2.71%)
  • Bid / Lots
    14.88/ 2
  • Ask / Lots
    44.62/ 2
  • Open / Previous Close
    29.70 / 30.53
  • Day Range
    29.70
    29.70
  • 52 Week Range
    26.29
    33.23
  • Volume
    79
  • Overall Morningstar Rating
    Not Ratedout of 268 funds

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Daily Premium/Discount

Bar Graph.See accessible table below
ETFs trading at a price higher than its Net Asset Value (NAV) is said to be trading at a premium, while those trading at price lower than its NAV is said to be at a discount. By showing the daily premium/discount percentage, we can see the trend in market sentiments, regarding the value of an ETF over time.

Holdings Diversification

Asset Class
US Stock		77.2%
Non-US Stock		19.7%
Cash		3.2%
Convertible		0
Non-US Bond		0
Other		0
Sectors
Healthcare57.0%
Basic Mat.20.6%
Technology7.5%
Consumer Defensive5.3%
Communication Services4.7%
Consumer Cyclical1.8%
Energy0
Financial Serv.s0
Industrials0
Real Estate0
Utilities0
Geographic Region
United States		79.7%
Europe		4.3%
Latin America		0
Africa		0
Canada		0
Asia/Oceania		0
As of 2024-09-30

Top 10 Holdings

Company NamePositionAllocation
Allocation
1 Month Change
Market Value
TMO
Thermo Fisher Scientific Inc
Long
6.9%
0.00%
$401.5K
DHR
Danaher Corp
Long
6.5%
0.00%
$376.4K
NVDA
NVIDIA Corp
Long
5.2%
0.00%
$303.1K
BIO
Bio-Rad Laboratories Inc Class A
Long
5.2%
0.00%
$301.5K
NVZMY
Novonesis (Novozymes) B ADR
Long
5.1%
0.00%
$298.1K
GOOGL
Alphabet Inc Class A
Long
4.7%
0.00%
$270.2K
CTVA
Corteva Inc
Long
4.4%
0.00%
$254.7K
ABBV
AbbVie Inc
Long
4.1%
-5.78%
$235.0K
LLY
Eli Lilly and Co
Long
3.8%
0.00%
$220.6K
DD
DuPont de Nemours Inc
Long
3.7%
0.00%
$212.3K
As of 2024-11-11

Reports

No reports available

Morningstar Ratings

Time HorizonStar Rating
Overall RatingNot Rated
3 Year RatingNot Rated
5 Year RatingNot Rated
10 Year RatingNot Rated
As of 2024-10-31

Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.

Style Box is calculated only using the long position holdings of the portfolio.

ETF Profile
Best Fit Index
N/A
Category
Health
Sponsor
Putnam Investment Management, LLC
Inception
September 29, 2022
As of 2024-09-30

The investment seeks long term capital appreciation. The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on “biology revolution” companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.

Holding Details
Total Net Assets$5.5M
Shares Out.175.0K
Net Asset Value (NAV)$29.75
Prem/Discount to NAV5.61%
P/E Ratio37.8
Dividend Yield0.07%
Dividend per Share0.02 USD
Ex-Dividend Date12/6/2023
Dividend Payment Date12/11/2023
Beta---
Morningstar Investment StyleHealth
Equity Style
Large Cap Growth
Credit Quality / Duration
---
Fees & Expenses
Actual Management Fee0.70%
Actual Mgmt. Expense Ratio (MER)0.69%